Skip to main content
. 2020 Jul 8;5(5):834–839. doi: 10.1016/j.adro.2020.06.021

Table 3.

Summary of acute toxicities

Toxicity Frequency (%)
None 17/65 (26.2%)
Headache 11/65 (16.9%)
Fatigue 15/65 (23.1%)
Seizure 1/65 (1.5%)
Focal symptoms improved 4/65 (6.2%)
Skin 4/65 (6.2%)
Weakness 5/65 (7.7%)
Memory changes 2/65 (3.1%)
Stopped radiation early 8/75 (10.7%)
Dexamethasone decreased/same/increased 10/31/16